{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:38:54Z","timestamp":1768084734392,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA049435"],"award-info":[{"award-number":["UG1DA049435"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.dadr.2024.100276","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T22:50:18Z","timestamp":1724453418000},"page":"100276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Impact of COVID-19 on MOUD retention in a sample of rural primary care patients: A secondary analysis of electronic health records"],"prefix":"10.1016","volume":"12","author":[{"given":"Stacy","family":"Calhoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Clingan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ing","family":"Hser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100276_bib1","unstructured":"Ahmad, F., Cisewki, J., Rossen, L., & Sutton, P. (2023). Provisional drug overdose death counts. National Center for Health Statistics. Https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm."},{"issue":"1","key":"10.1016\/j.dadr.2024.100276_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13011-021-00395-6","article-title":"The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review","volume":"16","author":"Alexander","year":"2021","journal-title":"Subst. Abus. Treat., Prev., Policy"},{"issue":"2","key":"10.1016\/j.dadr.2024.100276_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.dadr.2024.100276_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13722-022-00299-1","article-title":"Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community","volume":"17","author":"Biondi","year":"2022","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.dadr.2024.100276_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103931","article-title":"Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: a scoping review","volume":"112","author":"Bommersbach","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"2","key":"10.1016\/j.dadr.2024.100276_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery","year":"2015","journal-title":"Harv. Rev. Psychiatry"},{"issue":"32","key":"10.1016\/j.dadr.2024.100276_bib7","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.15585\/mmwr.mm6932a1","article-title":"Mental health, substance use, and suicidal ideation during the COVID-19 pandemic\u2014United States, June 24\u201330, 2020","volume":"69","author":"Czeisler","year":"2020","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2024.100276_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.107113","article-title":"Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race\/ethnicity, and gender in the United States","volume":"124","author":"Hochheimer","year":"2022","journal-title":"Addict. Behav."},{"issue":"4","key":"10.1016\/j.dadr.2024.100276_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jrh.12760","article-title":"Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: results from a single-arm, multisite feasibility study","volume":"39","author":"Hser","year":"2023","journal-title":"J. Rural Health"},{"issue":"1","key":"10.1016\/j.dadr.2024.100276_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13722-021-00233-x","article-title":"Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial","volume":"16","author":"Hser","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"1","key":"10.1016\/j.dadr.2024.100276_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jrh.12442","article-title":"COVID-19 during the opioid epidemic \u2013 exacerbation of stigma and vulnerabilities","volume":"37","author":"Jenkins","year":"2021","journal-title":"J. Rural Health"},{"key":"10.1016\/j.dadr.2024.100276_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108270","article-title":"Substance use treatment in Appalachian Tennessee amid COVID-19: challenges and preparing for the future","volume":"124","author":"Kedia","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.dadr.2024.100276_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109711","article-title":"Telemedicine along the cascade of care for substance use disorders during the COVID-19 pandemic in the United States","volume":"242","author":"Lin","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100276_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108158","article-title":"A clash of epidemics: impact of the COVID-19 pandemic response on opioid overdose","volume":"120","author":"Linas","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.dadr.2024.100276_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","volume":"46","author":"Lister","year":"2020","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"19","key":"10.1016\/j.dadr.2024.100276_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6619a1","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas\u2014United States","volume":"66","author":"Mack","year":"2017","journal-title":"Mmwr. Surveill. Summ."},{"issue":"0","key":"10.1016\/j.dadr.2024.100276_bib17","first-page":"1","article-title":"The impact of the COVID-19 pandemic on medications for opioid use disorder services in the U.S. and Canada: a scoping review","volume":"0","author":"Parker","year":"2023","journal-title":"Drug.: Educ.\u00a0Prev. Policy"},{"key":"10.1016\/j.dadr.2024.100276_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ssmmh.2022.100151","article-title":"Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study","volume":"2","author":"Poulsen","year":"2022","journal-title":"SSM - Ment. Health"},{"key":"10.1016\/j.dadr.2024.100276_bib19","unstructured":"RAND Corporation. (2021). Quality Metrics Technical Documentation. Available from: Https:\/\/www.rand.org\/content\/dam\/rand\/pubs\/tools\/TLA900\/TLA928-1\/resources\/step-4\/OUD\/RAND_TLA928-1.technical-documentation_OUD.pdf."},{"key":"10.1016\/j.dadr.2024.100276_bib20","unstructured":"Rural Health Information Hub. (2023) Am I Rural?\u2014Tool. Available from: https:\/\/www.ruralhealthinfo.org\/am-i-rural."},{"key":"10.1016\/j.dadr.2024.100276_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.dadr.2024.100276_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/rmh0000187","article-title":"Medication for opioid use disorder in rural America: a review of the literature","volume":"45","author":"Showers","year":"2021","journal-title":"J. Rural Ment. Health"},{"key":"10.1016\/j.dadr.2024.100276_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108661","article-title":"Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine","volume":"136","author":"Stein","year":"2022","journal-title":"J. Subst. Abus. Treat."},{"issue":"22","key":"10.1016\/j.dadr.2024.100276_bib24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277272462400060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277272462400060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:10:34Z","timestamp":1726704634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277272462400060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":24,"alternative-id":["S277272462400060X"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100276","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 on MOUD retention in a sample of rural primary care patients: A secondary analysis of electronic health records","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100276","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100276"}}